Aglaia is an oncology specialist investor which selects and matures early-stage breakthrough inventions that have the potential to transform cancer prevention, diagnosis and therapy.
Employees: 1-10
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 11
| Date | Name | Website | Total Raised | Location |
| - | Merus N.V. | merus.nl | $157.12M | Netherland... |
| - | Modra Phar... | modrapharm... | - | Netherland... |
| - | MIMETAS - ... | mimetas.co... | $25.2M | Netherland... |
| - | Macrophage... | macrophage... | - | United Kin... |
| - | Cristal Th... | cristalthe... | $21.11M | Netherland... |
| - | ISA Pharma... | isa-pharma... | $30.78M | Netherland... |
| - | InteRNA Te... | interna-te... | $32.92M | - |
| - | Synthon | synthon.co... | - | Netherland... |
| - | Inthera | intherabio... | $16.38M | - |
| - | Sapreme Te... | sapreme-te... | $17.35M | Netherland... |
Show more
Persons 6
| Date | First Name | Last Name | Title | Location | |||
| - | Mark | Krul | - | linkedin.c... | - | k**l@aglai... | - |
| - | Eric | van der Pu... | - | linkedin.c... | - | e**p@aglai... | - |
| - | Karl | Rothweiler | - | - | k*r@aglaia... | - | |
| - | Folkert | van Cleef | - | linkedin.c... | - | f*c@aglaia... | - |
| - | Angelique | Hermeling | - | linkedin.c... | - | a*h@aglaia... | - |
| - | Ernst | Geutjes | - | linkedin.c... | - | i**o@aglai... | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 12.04.2022 | Bpifrance backs Ribonexus with €2 million to develop melanom... | French biotechnology startup Ribonexus has raised €2 million in funding from the French public inves... | tech.eu/20... |
| - | Bpifrance backs Ribonexus with €2 million to develop melanom... | French biotechnology startup Ribonexus has raised €2 million in funding from the French public inves... | tech.eu/20... |